Publication | Open Access
BI-907828, a novel potent MDM2 inhibitor, inhibits glioblastoma brain tumor stem cells in vitro and prolongs survival in orthotopic xenograft mouse models
31
Citations
30
References
2022
Year
BI-907828 provides a promising new therapeutic option for patients with TP53 wild-type primary brain tumors.
| Year | Citations | |
|---|---|---|
Page 1
Page 1